Dr Reddy’s slides to 52-week low: Brokerages slash price target on Semaglutide API, Middle East concerns
- Posted on July 23, 2026
- By Financial Express
- 0 Views
- 1 min read
In brief
Generating AI summary…
Dr Reddy’s slides to 52-week low: Brokerages slash price target on Semaglutide API, Middle East concerns
Dr Reddy’s hits a 52-week low after weak Q1 earnings, Semaglutide API issues and Middle East costs trigger target cuts; read the outlook.
